Fig. 4.
Survival data in reference patients 50 years or younger with follicular small cleaved or mixed lymphoma managed at Stanford University.
(A) Overall survival (n = 188, solid line), disease-specific survival (n = 188, dotted line) and freedom from progression (n = 138 with exclusion of no initial therapy patients, dotted and dashed line). (B) Overall survival for high tumor burden at diagnosis (n = 92, solid line) versus low tumor burden (n = 96, dotted line), P = .001. (C) Overall survival for 61 patients treated with CVP who achieved a complete or equivocal complete response (n = 48, solid line) versus partial response (n = 13, dotted line),P = .03.